Apidaecin IB acetate

TargetMol
Product Code: TAR-T10347L
Supplier: TargetMol
CodeSizePrice
TAR-T10347L-1mg1mg£222.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10347L-2mg2mg£293.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10347L-5mg5mg£410.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10347L-10mg10mg£573.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10347L-25mg25mg£870.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10347L-1mL1 mL * 10 mM (in DMSO)£962.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10347L-50mg50mg£1,139.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10347L-100mg100mg£1,508.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Further Information

Bioactivity:
Apidaecin IB acetate is an insect antibacterial peptide. The minimum concentration of apidaecin IB acetate against Escherichia coli (E. coli ML35, o18k1h7 and ATCC 25922) is 8 μM.
CAS:
T10347L
Formula:
C97H154N32O25
Molecular Weight:
2168.46
Purity:
0.9991
SMILES:
CC(C)C[C@@H](C(O)=O)NC([C@H](CCCNC(N)=N)NC([C@H]1N(C([C@H](CC2=CNC=N2)NC([C@H]3N(C([C@H]4N(C([C@H](CCCNC(N)=N)NC([C@H]5N(C([C@H](CCC(N)=O)NC([C@H]6N(C([C@H]([C@@H](C)CC)NC([C@H](CC7=CC=C(O)C=C7)NC([C@H](C(C)C)NC([C@H]8N(C([C@H](CCCNC(N)=N)NC([C@H](CC(N)=O)NC([C@H](CC(N)=O)NC(CN)=O)=O)=O)=O)CCC8)=O)=O)=O)=O)CCC6)=O)=O)CCC5)=O)=O)CCC4)=O)CCC3)=O)=O)CCC1)=O)=O.CC(O)=O

References

1. Gobbo M, et al. Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation. J Med Chem. 2009 Aug 27;52(16):5197-206.